Deals & Cases |
Deals & Cases | 26 ottobre 2017
Nouscom AG EUR 42 Mio. Serie B Finanzierungsrunde
Walder Wyss berät Abingworth und 5AM Venture im Rahmen von Nouscom’s Serie B Finanzierungsrunde. Nouscom entwickelt tumorspezifische onkologische Viren und patientenspezifische Krebsimpfungen. Die Finanzierungsrunde wurde gezeichnet von Abingworth und 5AM Venture sowie von bestehenden Aktionären.
Das Walder Wyss Team setzt sich zusammen aus Alexander Gutmans (Partner, Corporate, Venture Capital) und Jessica Aeschbach Flórez (Associate, Corporate).
Altre notizie
-
Deals & Cases | -
Deals & Cases |Walder Wyss advised 3VC on its investment in Aderis
-
Deals & Cases |Distalmotion SA – USD 70 million Term Loan Facility from Perceptive Advisors
-
Deals & Cases |Oversubscribed USD 135 Million Series D Financing Round of Nouscom
-
Deals & Cases |Walder Wyss with the banking syndicate on Sandoz EUR 500 million bond issuance
-
Deals & Cases |Walder Wyss advises Spital Emmental AG on syndicated credit facilities
-
Corporate News |The New Advisor Regime under the Revised Swiss Anti-Money Laundering Act: Qualifying Mandates in Practice
-
Deals & Cases |Walder Wyss advises on the refinancing of River Advice AG
-
Deals & Cases |Affidea acquires Zentrum für Integrative Onkologie (ZIO)
-
Premi e riconoscimenti |IFLR1000 Rankings 2026: Walder Wyss recognised as a top-tier law firm